Status:

RECRUITING

Development of New Personalised 3D Preclinical Models of Pancreatic Neuroendocrine Tumours

Lead Sponsor:

IRCCS San Raffaele

Conditions:

Pancreatic Neuroendocrine Tumor

Eligibility:

All Genders

18+ years

Brief Summary

The goal of this prospective observational study is to generate new personalised 3D preclinical models of pancreatic neuroendocrine tumors. The models will be exploited for studying the mechanisms und...

Detailed Description

Pancreatic neuroendocrine tumors (PanNETs) are characterized by highly heterogeneous biological behavior. Another distinctive feature of these neoplasms is the presence of a dense vascular network, re...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • patients who undergo pancreatic surgical resection for non-functioning pancreatic neuroendocrine tumor
  • age ≥ 18 years
  • informed consent
  • Exclusion criteria:
  • non-pancreatic neuroendocrine tumor histological diagnosis
  • age \< 18 years

Exclusion

    Key Trial Info

    Start Date :

    January 16 2024

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2029

    Estimated Enrollment :

    70 Patients enrolled

    Trial Details

    Trial ID

    NCT06121622

    Start Date

    January 16 2024

    End Date

    December 1 2029

    Last Update

    May 1 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS San Raffele Institute

    Milan, MI, Italy, 20132